Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Neelam S. Amin is active.

Publication


Featured researches published by Neelam S. Amin.


Protein Expression and Purification | 2009

Generation and identification of variants with improved purification yield of Bowman-Birk protease inhibitors carrying protein binding loops.

Katherine D. Collier; Gudrun Vogtentanz; Neelam S. Amin; Melodie Estabrook; David A. Estell; Bryan P. Fox; Scott D. Power; Roopali Rao; Brian Schmidt

Replacing the chymotrypsin inhibitory loop of soybean Bowman-Birk inhibitor (sBBI) with a VEGF binding peptide (BBI-AV) significantly reduces the overall purification yield when BBI-AV is produced as a fusion protein in a Bacillussubtilis expression system. The low purification yield is primarily due to a higher fraction of molecules with incorrect disulfide bond configurations after production and also after disulfide bond shuffling induced by 2-mercaptoethanol. To improve production yields, site-saturation libraries were generated at 39 out of the 66 amino acid residues of BBI-AV. Initial screens were designed to select for variants with higher trypsin inhibitory activities than the parent after treatment with a reducing agent. Secondary screens were developed to select for variants with the highest purification yields, and to also eliminate any false positives. From the screens, it was found that positively charged substitutions in the exposed hydrophobic patch region (sites 27, 29, 40, 50 & 52) are especially productive. In fact, one substitution, F50R, improves the purification yield to nearly the same level as wild-type sBBI. Productive amino acid substitutions were combined to select for the variant with the best overall yield after purification. Several variants were obtained with higher purification yields than even sBBI. The octuple variants, A13I-S25R-M27A-L29P-S31A-A40H-F50K-V52T and A13I-S25K-M27A-L29R-S31E-A40K-F50Q-V52Q, are particularly productive having greater than a five fold increase in final purification yield over the parent.


Archive | 2009

Compositions and methods comprising serine protease variants

Philip Frank Souter; Euan John Magennis; Glenn Steven Ward; Neelam S. Amin; Katherine Augustyn; Joshua Roy Basler; Luis G. Cascao-Pereira; Katherine D. Collier; Edward M. Concar; David A. Estell; James T. Kellis; Alexander Pisarchik; Ayrookaran J. Poulose; Jian Yao


Archive | 2008

Variants of an alpha-amylase with improved production levels in fermentation processes

Wolfgang Aehle; Neelam S. Amin


Archive | 2007

Compositions and uses for an alpha-amylase polypeptide of bacillus species 195

Neelam S. Amin; Melodie Estabrook; Brian E. Jones; Marc Kolkman; Casper Vroemen; Walter Weyler


Archive | 2008

Modified variant Bowman Birk Protease Inhibitors

Neelam S. Amin; Katherine D. Collier; Melodie Estabrook; David A. Estell; Bryan P. Fox; Scott D. Power; Brian Schmidt; Gudrun Vogtentanz


Archive | 2008

Improved variants of the bacillus licheniformis alpha-amylase

Wolfgang Aehle; Neelam S. Amin


Archive | 2008

PERSONAL CARE COMPOSITIONS COMPRISING MODIFIED VARIANT BOWMAN BIRK PROTEASE INHIBITORS

Neelam S. Amin; Katherine D. Collier; Melodie Estabrook; David A. Estell; Bryan P. Fox; Scott D. Power; Brian Schmidt; Gudrun Vogtentanz


BioTechniques | 2003

Direct transformation of site-saturation libraries in Bacillus subtilis

Neelam S. Amin; Stephanie Wong; Volker Schellenberger


Archive | 2008

VARIANTS OF THE BACILLUS LICHENIFORMIS ALPHA-AMYLASE

Wolfgang Aehle; Neelam S. Amin


Archive | 2017

METHODS AND COMPOSITIONS COMPRISING SERINE PROTEASE VARIANTS

Neelam S. Amin; Katherine Augustyn; Basler Joshua R; Luis G. Cascao-Pereira; Katherine D. Collier; Edward M. Concar; Estell David A; James T. Kellis; Euan John Magennis; Alexander Pisarchik; Ayrookaran J. Poulose; Philip Frank Souter; Glenn Steven Ward; Yao Jian

Collaboration


Dive into the Neelam S. Amin's collaboration.

Researchain Logo
Decentralizing Knowledge